Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03989986 · ClinicalTrials.gov registry record · NA
iPeer2Peer Program for Youth With Sickle Cell Disease
A NA study of Sickle Cell Disease, sponsored by The Hospital for Sick Children.
- Active
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 4
- Study locations
NCT03989986: Active NA study of Sickle Cell Disease, sponsored by The Hospital for Sick Children.
NCT03989986 is a NA study of Sickle Cell Disease that is active but no longer recruiting, run by The Hospital for Sick Children. The registered enrollment target is 28 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03989986, a NA study of Sickle Cell Disease, is active but no longer recruiting, sponsored by The Hospital for Sick Children.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 4
- Study locations
Study Summary
The iPeer2Peer Sickle Cell Disease (SCD) study matches youth (12-18 years of age) with SCD to a mentor (trained young adult) who has learned to manage their SCD well, transitioned to adult care, and can support youth participants emotionally and socially. Participants will be randomly assigned one of two groups, either (1) The intervention group: Study group participants are matched with a mentor for 15 weeks, and are expected to have up to ten calls with one another; (2) The control group: This study group will be on a 15 week waitlist to receive a mentor. This study will first assess the feasibility of conducting this research with youth with SCD. Also, this study will assess the preliminary effectiveness of peer mentorship by comparing various health outcomes of the two study groups post-intervention.
Conditions Studied
Interventions
- BEHAVIORAL iPeer2Peer Mentorship
Study Locations (4)
Ontario
- Children's Hospital of Eastern Ontario (CHEO) - Ottawa
- The Hospital for Sick Children - Toronto
Connecticut
- Connecticut Children's Medical Center - Hartford
Saskatchewan
- Jim Pattison - Saskatoon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the registry record for NCT03989986 still lists
NCT03989986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which iPeer2Peer Mentorship is the first listed.
NCT03989986 reports a single indexed study location in Ontario, Connecticut, Saskatchewan.
Frequently Asked Questions
What is clinical trial NCT03989986 about?
NCT03989986 is a clinical study titled "iPeer2Peer Program for Youth With Sickle Cell Disease". The iPeer2Peer Sickle Cell Disease (SCD) study matches youth (12-18 years of age) with SCD to a mentor (trained young adult) who has learned to manage their SCD well, transitioned to adult care, and can support youth participants emotionally and socially. Participants will be randomly assigned one o...
What is the current status of trial NCT03989986?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2020-01-01. Estimated completion is 2024-12-31.
What conditions does trial NCT03989986 study?
This clinical trial studies the following conditions: Sickle Cell Disease.
What interventions are being tested in trial NCT03989986?
The interventions under investigation include: iPeer2Peer Mentorship (BEHAVIORAL).
Who is sponsoring clinical trial NCT03989986?
This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03989986 being conducted?
This trial has 4 study locations across Connecticut, Ontario, Saskatchewan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03989986's enrollment target sits among peer trials
28 148th of 213 higher than 64 of 213 other Sickle Cell Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI